Health Condition 1: L00-L08- Infections of the skin and subcutaneous tissue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients of either gender and age 18 - 60 yrs 2) Patients with clinical diagnosed symptomatic oral lichen planus 3) Patients willing to participate in the study and for follow up
Exclusion criteria
Exclusion criteria: 1)Patients having systemic disorders such as hyperthyroidism, severe anaemia and G6PD Deficiency are excluded 2)Patients who are undergoing any other treatment for oral lichen planus. 3)Patients who showed dysplasia on velscope examination 4)Patients who are not co operative with the application of topical steroid therapy and ozonated olive oil according to the instructions given will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome for application of ozonated olive oil results in reduction in burning sensation and pain reduction on lesion size and severity anti inflammatory effect no systemic side effects improved patient compliance resulting in non stinging , soothing nature that promotes adherence Unlike corticosteroids ozone does not suppress immunityTimepoint: Patients will be evaluated on the 7th 14th 21st 28th day and will be followed up for 2 to 4 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effect of ozonated olive oil on the subjective symptoms of oral lichen planus , including pain relief, burning sensation and patient reported quality of life as well as to monitor for any adverse reactions , recurrence rate and tolerability of the treatment over the study periodTimepoint: The patient will be evaluated on the 7th,14th,21st,28th,2months and 6 months during the course of the study | — |
Countries
India